4: A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter (A01-M121-11A, MCG1132)
Titel:
4: A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter (A01-M121-11A, MCG1132)
Auteur:
Faye, Mame Daro Sabri, Siham Robles, Paula De Easaw, Jacob Agnihotram, Raman Torres-Vasquez, Alexander Panet-Raymond, Valerie Shenouda, George Souhami, Luis Abdulkarim, Bassam